Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2007
Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection modelPaul G Ambrose, Alan Forrest, William A Craig, et al.
Diagnostic Microbiology and Infectious Disease|March 24, 2000
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremiaS M Bhavnani, J A Drake, A Forrest, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2024
Population pharmacokinetic analyses for sulbactam-durlobactam using Phase 1, 2, and 3 dataAnthony P Cammarata, M Courtney Safir, Michael Trang, et al.
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|February 28, 2015
Neonatal late-onset sepsis following peripherally inserted central catheter removal: association with antibiotic use and adverse line eventsMichelle A Hoffman, Jessica N Snowden, Kari A Simonsen, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection ModelBrian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 9, 2003
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitalsSujata M Bhavnani, Wendy A Callen, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumoniaChristopher M Rubino, Sujata M Bhavnani, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult SubjectsChristopher M Rubino, Sujata M Bhavnani, Jeffery S Loutit, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Population pharmacokinetic analyses for BC-3781 using phase 2 data from patients with acute bacterial skin and skin structure infectionsC M Rubino, B Xue, S M Bhavnani, et al.
Pageof 21